The global Continuous Glucose Monitoring (CGM) market size was valued at USD 4745.5 million in 2023 and is forecast to a readjusted size of USD 6054.3 million by 2030 with a CAGR of 3.5% during review period.
A continuous glucose monitoring (CGM) system may help in these cases. The system consists of a small disposable sensor inserted into the skin, a transmitter connected to the sensor by a sensor mount wirelessly transmits results to a receiver and displays results.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report includes an overview of the development of the Continuous Glucose Monitoring (CGM) industry chain, the market status of Hospitals (Transmitters, Sensors), Homecare Settings (Transmitters, Sensors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Continuous Glucose Monitoring (CGM).
Regionally, the report analyzes the Continuous Glucose Monitoring (CGM) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Continuous Glucose Monitoring (CGM) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Continuous Glucose Monitoring (CGM) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Continuous Glucose Monitoring (CGM) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Transmitters, Sensors).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Continuous Glucose Monitoring (CGM) market.
Regional Analysis: The report involves examining the Continuous Glucose Monitoring (CGM) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Continuous Glucose Monitoring (CGM) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Continuous Glucose Monitoring (CGM):
Company Analysis: Report covers individual Continuous Glucose Monitoring (CGM) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Continuous Glucose Monitoring (CGM) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Homecare Settings).
Technology Analysis: Report covers specific technologies relevant to Continuous Glucose Monitoring (CGM). It assesses the current state, advancements, and potential future developments in Continuous Glucose Monitoring (CGM) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Continuous Glucose Monitoring (CGM) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Continuous Glucose Monitoring (CGM) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Transmitters
Sensors
Insulin Pumps
Market segment by Application
Hospitals
Homecare Settings
Others
Major players covered
Pfizer
Baxter
Abbott Laboratories
Medtronic
Animas
Novo Nordisk
Ypsomed
GlySens
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Continuous Glucose Monitoring (CGM) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Continuous Glucose Monitoring (CGM), with price, sales, revenue and global market share of Continuous Glucose Monitoring (CGM) from 2019 to 2024.
Chapter 3, the Continuous Glucose Monitoring (CGM) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Continuous Glucose Monitoring (CGM) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Continuous Glucose Monitoring (CGM) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Continuous Glucose Monitoring (CGM).
Chapter 14 and 15, to describe Continuous Glucose Monitoring (CGM) sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Continuous Glucose Monitoring (CGM)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Continuous Glucose Monitoring (CGM) Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Transmitters
1.3.3 Sensors
1.3.4 Insulin Pumps
1.4 Market Analysis by Application
1.4.1 Overview: Global Continuous Glucose Monitoring (CGM) Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Homecare Settings
1.4.4 Others
1.5 Global Continuous Glucose Monitoring (CGM) Market Size & Forecast
1.5.1 Global Continuous Glucose Monitoring (CGM) Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Continuous Glucose Monitoring (CGM) Sales Quantity (2019-2030)
1.5.3 Global Continuous Glucose Monitoring (CGM) Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Continuous Glucose Monitoring (CGM) Product and Services
2.1.4 Pfizer Continuous Glucose Monitoring (CGM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments/Updates
2.2 Baxter
2.2.1 Baxter Details
2.2.2 Baxter Major Business
2.2.3 Baxter Continuous Glucose Monitoring (CGM) Product and Services
2.2.4 Baxter Continuous Glucose Monitoring (CGM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Baxter Recent Developments/Updates
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Continuous Glucose Monitoring (CGM) Product and Services
2.3.4 Abbott Laboratories Continuous Glucose Monitoring (CGM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Abbott Laboratories Recent Developments/Updates
2.4 Medtronic
2.4.1 Medtronic Details
2.4.2 Medtronic Major Business
2.4.3 Medtronic Continuous Glucose Monitoring (CGM) Product and Services
2.4.4 Medtronic Continuous Glucose Monitoring (CGM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Medtronic Recent Developments/Updates
2.5 Animas
2.5.1 Animas Details
2.5.2 Animas Major Business
2.5.3 Animas Continuous Glucose Monitoring (CGM) Product and Services
2.5.4 Animas Continuous Glucose Monitoring (CGM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Animas Recent Developments/Updates
2.6 Novo Nordisk
2.6.1 Novo Nordisk Details
2.6.2 Novo Nordisk Major Business
2.6.3 Novo Nordisk Continuous Glucose Monitoring (CGM) Product and Services
2.6.4 Novo Nordisk Continuous Glucose Monitoring (CGM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Novo Nordisk Recent Developments/Updates
2.7 Ypsomed
2.7.1 Ypsomed Details
2.7.2 Ypsomed Major Business
2.7.3 Ypsomed Continuous Glucose Monitoring (CGM) Product and Services
2.7.4 Ypsomed Continuous Glucose Monitoring (CGM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Ypsomed Recent Developments/Updates
2.8 GlySens
2.8.1 GlySens Details
2.8.2 GlySens Major Business
2.8.3 GlySens Continuous Glucose Monitoring (CGM) Product and Services
2.8.4 GlySens Continuous Glucose Monitoring (CGM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 GlySens Recent Developments/Updates
3 Competitive Environment: Continuous Glucose Monitoring (CGM) by Manufacturer
3.1 Global Continuous Glucose Monitoring (CGM) Sales Quantity by Manufacturer (2019-2024)
3.2 Global Continuous Glucose Monitoring (CGM) Revenue by Manufacturer (2019-2024)
3.3 Global Continuous Glucose Monitoring (CGM) Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Continuous Glucose Monitoring (CGM) by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Continuous Glucose Monitoring (CGM) Manufacturer Market Share in 2023
3.4.2 Top 6 Continuous Glucose Monitoring (CGM) Manufacturer Market Share in 2023
3.5 Continuous Glucose Monitoring (CGM) Market: Overall Company Footprint Analysis
3.5.1 Continuous Glucose Monitoring (CGM) Market: Region Footprint
3.5.2 Continuous Glucose Monitoring (CGM) Market: Company Product Type Footprint
3.5.3 Continuous Glucose Monitoring (CGM) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Continuous Glucose Monitoring (CGM) Market Size by Region
4.1.1 Global Continuous Glucose Monitoring (CGM) Sales Quantity by Region (2019-2030)
4.1.2 Global Continuous Glucose Monitoring (CGM) Consumption Value by Region (2019-2030)
4.1.3 Global Continuous Glucose Monitoring (CGM) Average Price by Region (2019-2030)
4.2 North America Continuous Glucose Monitoring (CGM) Consumption Value (2019-2030)
4.3 Europe Continuous Glucose Monitoring (CGM) Consumption Value (2019-2030)
4.4 Asia-Pacific Continuous Glucose Monitoring (CGM) Consumption Value (2019-2030)
4.5 South America Continuous Glucose Monitoring (CGM) Consumption Value (2019-2030)
4.6 Middle East and Africa Continuous Glucose Monitoring (CGM) Consumption Value (2019-2030)
5 Market Segment by Type
5.1 Global Continuous Glucose Monitoring (CGM) Sales Quantity by Type (2019-2030)
5.2 Global Continuous Glucose Monitoring (CGM) Consumption Value by Type (2019-2030)
5.3 Global Continuous Glucose Monitoring (CGM) Average Price by Type (2019-2030)
6 Market Segment by Application
6.1 Global Continuous Glucose Monitoring (CGM) Sales Quantity by Application (2019-2030)
6.2 Global Continuous Glucose Monitoring (CGM) Consumption Value by Application (2019-2030)
6.3 Global Continuous Glucose Monitoring (CGM) Average Price by Application (2019-2030)
7 North America
7.1 North America Continuous Glucose Monitoring (CGM) Sales Quantity by Type (2019-2030)
7.2 North America Continuous Glucose Monitoring (CGM) Sales Quantity by Application (2019-2030)
7.3 North America Continuous Glucose Monitoring (CGM) Market Size by Country
7.3.1 North America Continuous Glucose Monitoring (CGM) Sales Quantity by Country (2019-2030)
7.3.2 North America Continuous Glucose Monitoring (CGM) Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
8.1 Europe Continuous Glucose Monitoring (CGM) Sales Quantity by Type (2019-2030)
8.2 Europe Continuous Glucose Monitoring (CGM) Sales Quantity by Application (2019-2030)
8.3 Europe Continuous Glucose Monitoring (CGM) Market Size by Country
8.3.1 Europe Continuous Glucose Monitoring (CGM) Sales Quantity by Country (2019-2030)
8.3.2 Europe Continuous Glucose Monitoring (CGM) Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Continuous Glucose Monitoring (CGM) Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Continuous Glucose Monitoring (CGM) Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Continuous Glucose Monitoring (CGM) Market Size by Region
9.3.1 Asia-Pacific Continuous Glucose Monitoring (CGM) Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Continuous Glucose Monitoring (CGM) Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
10.1 South America Continuous Glucose Monitoring (CGM) Sales Quantity by Type (2019-2030)
10.2 South America Continuous Glucose Monitoring (CGM) Sales Quantity by Application (2019-2030)
10.3 South America Continuous Glucose Monitoring (CGM) Market Size by Country
10.3.1 South America Continuous Glucose Monitoring (CGM) Sales Quantity by Country (2019-2030)
10.3.2 South America Continuous Glucose Monitoring (CGM) Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Continuous Glucose Monitoring (CGM) Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Continuous Glucose Monitoring (CGM) Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Continuous Glucose Monitoring (CGM) Market Size by Country
11.3.1 Middle East & Africa Continuous Glucose Monitoring (CGM) Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Continuous Glucose Monitoring (CGM) Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
12.1 Continuous Glucose Monitoring (CGM) Market Drivers
12.2 Continuous Glucose Monitoring (CGM) Market Restraints
12.3 Continuous Glucose Monitoring (CGM) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Continuous Glucose Monitoring (CGM) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Continuous Glucose Monitoring (CGM)
13.3 Continuous Glucose Monitoring (CGM) Production Process
13.4 Continuous Glucose Monitoring (CGM) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Continuous Glucose Monitoring (CGM) Typical Distributors
14.3 Continuous Glucose Monitoring (CGM) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Pfizer
Baxter
Abbott Laboratories
Medtronic
Animas
Novo Nordisk
Ypsomed
GlySens
听
听
*If Applicable.
